Form 4: Linde Executive VP Reports Routine Share Transactions and Option Exercises

Sentiment:

Insider Transaction Report 27 May 2025 4:31 PM

Sean Durbin, Executive VP, North America at Linde PLC, reported a series of transactions including the exercise of stock options and subsequent sale of shares, along with tax-related withholdings, on May 22, 2025.

Summary

Sean Durbin, Executive VP, North America for Linde PLC, engaged in multiple transactions involving the company's ordinary shares on May 22, 2025.
He exercised 7,795 stock options at an exercise price of $176.63 per share, increasing his beneficial ownership.
Following the option exercise, he disposed of 4,637.459 ordinary shares at $456.193 per share and an additional 2,624 ordinary shares at $456.82 per share.
A total of 5,171 ordinary shares were withheld by the company at a price of $456.82 per share to cover the exercise price and tax withholdings related to the option exercise.
After all reported transactions, Mr. Durbin's direct beneficial ownership of Linde PLC ordinary shares stands at 8,150.559.
The filing also details various unvested derivative securities held by Mr. Durbin, including stock options, restricted stock units (RSUs), and deferred stock units (DSUs), with various vesting and expiration dates extending to 2035.

Sentiment

Score: 5

Explanation: The document is a routine SEC Form 4 filing detailing insider transactions. It does not contain information that would significantly alter the sentiment towards the company, as the transactions appear to be standard executive compensation monetization and tax-related dispositions.

Positives

The exercise of stock options by the Executive VP indicates the monetization of vested equity, which is a standard component of executive compensation.
The significant difference between the option exercise price ($176.63) and the sale prices ($456.193 and $456.82) demonstrates a profitable transaction for the executive, reflecting an increase in Linde's share value since the options were granted.

Negatives

The sale of shares, even if for tax purposes or diversification, results in a reduction of the executive's direct equity stake in the company.

Future Outlook

The document primarily details past and current transactions related to executive compensation. It does not provide forward-looking statements or guidance regarding the company's financial performance or strategic direction, beyond the future vesting schedules and payout dates for various derivative securities held by the executive.

Management Comments

The filing itself is a report by Sean Durbin, Executive VP, North America, through his attorney-in-fact, Anthony M. Pepper, detailing changes in his beneficial ownership of Linde PLC securities.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity, specifically related to executive compensation and personal investment management. It does not provide broader industry context or trends.

Related Party Transactions

The transactions involve an executive of Linde PLC and the company's securities, which are considered related party dealings in the context of insider reporting.

Stakeholder Impact

Shareholders: Routine insider transactions typically have minimal direct impact on shareholders, as they are often related to executive compensation and personal financial planning.
Employees: No direct impact on employees is indicated by this filing.
Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Next Steps

Future vesting of various stock options, with installments beginning on dates such as March 7, 2025, March 7, 2026, March 7, 2027, March 7, 2028, March 7, 2032, March 7, 2033, March 7, 2034, and March 7, 2035.
Payout of Restricted Stock Units on or about March 7, 2026, March 7, 2027, and March 7, 2028.
Payout of Deferred Stock Units in accordance with the Linde Compensation Deferral Plan.

Key Dates

Date	Description
03/20/2020	Start of vesting for a tranche of stock options.
03/09/2021	Start of vesting for a tranche of stock options.
03/07/2022	Grant date for Performance Share Units (PSU) and start of vesting for a tranche of stock options.
03/08/2022	Start of vesting for a tranche of stock options.
03/07/2023	Start of vesting for a tranche of stock options.
03/07/2024	Start of vesting for a tranche of stock options.
03/07/2025	Start of vesting for a tranche of stock options; payout date for certain Restricted Stock Units.
03/10/2025	Payout date for Performance Share Units (PSU) based on Return on Capital (ROC) performance from 2022-2025.
05/22/2025	Date of reported transactions including stock option exercise, share sales, and tax withholdings.
05/27/2025	Signature date of the Form 4 filing.
03/07/2026	Start of vesting for a tranche of stock options; payout date for certain Restricted Stock Units.
03/07/2027	Payout date for certain Restricted Stock Units.
03/07/2028	Payout date for certain Restricted Stock Units; expiration date for certain stock options.
03/20/2029	Expiration date for certain stock options.
03/09/2030	Expiration date for certain stock options.
03/08/2031	Expiration date for certain stock options.
03/07/2032	Expiration date for certain stock options.
03/07/2033	Expiration date for certain stock options.
03/07/2034	Expiration date for certain stock options.
03/07/2035	Expiration date for certain stock options.

Keywords

Linde PLC, LIN, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Executive Compensation, Share Ownership, Beneficial Ownership, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.